A Successful Transition from Europe to the US Market
To ensure broad access for their supportive care technology, a European-based medical device company looking to enter the US market sought guidance and support in understanding the US payer system and how to gain buy-in from US healthcare providers.
The IP Solution
To help this European-based company navigate the complexities of the US Healthcare Landscape, our first step was to engage thought leaders across major academic cancer centers and community oncology networks to gain support for the product.
The next step was to achieve inclusion for the product within the clinical compendia as a supportive care treatment across multiple tumor types. We engaged in a series of meetings with thought leaders to garner insight, and then— with support from our team of expert medical writers—provided critical guidance to the company’s internal team in writing and submitting formal requests to major oncology clinical compendia organizations.
[IP has] a huge amount of experience and connections in the industry but what I love about them is that they are honest, supportive and ultimately want us to succeed.
The strategy proved successful, and the device was recognized within the clinical guidelines and compendia, ensuring access for providers and payers.